Promoting XXcellence in Women's Health: Optimal Management of Women and Girls with Bleeding Disorders: Special Research Award*
Award Target: Junior Faculty or Fellows
Number of Awards Given: 2
Amount of each Award: $35,000
Application Due Date: Friday, October 29, 2021 (11:59 PM EDT)
Download the FWGBD Special Research Grant Award Process Description and Criteria (PDF) HERE
Download the Award Application Form (PDF) HERE
Download the Download the Specifications for Fulfilling the Grant Requirements (PDF) HERE
Menstruation, pregnancy, childbirth, and menopause present unique challenges in women and girls with blood disorders. Undiagnosed, untreated blood disorders in women have medical consequences at every life stage. Delay and/or failure in diagnosing and appropriately treating blood disorders in women and girls are major public health problems, resulting in significant morbidity, reduced quality of life, days lost from work and school, unnecessary invasive procedures and high healthcare costs.
It took the experience and training of three internationally recognized physicians in women’s blood disorders, Drs. Andra James, obstetrics and gynecology, Barbara Konkle and Roshni Kulkarni, hematology, underscored the need for a foundation focused on education and awareness. Their discussions culminated in the Foundation for Women & Girls with Blood Disorders (FWGBD). In 2010, the FWGBD, a non-profit 501(c)3 organization, was launched to serve as a single site, single source of information and education for physicians and healthcare providers.
FWGBD’s Mission is to ensure that all women and girls with blood disorders are correctly diagnosed and optimally managed at every life stage by:
- Raising awareness and educating the key healthcare providers for each particular life stage, including but not limited to, pediatricians, family practice providers, internal medicine physicians, obstetricians, gynecologists, hematologists/oncologists, geriatricians, nurse practitioners, physician assistants, nurses and social workers
- Translating and disseminating provider information and research
- Providing support for and encouraging research in this area
The Foundation is dedicated to achieving the correct diagnosis and optimal treatment of blood disorders and accompanying reproductive problems in women and girls with bleeding disorders--von Willebrand disease (VWD), other clotting factor deficiencies, inherited and acquired platelet disorders including immune thrombocytopenic purpura (ITP); the thrombophilias; sickle cell disease (SCD) and sickle cell trait (SCT); and all anemias.
FWGBD has been effectively gaining recognition and momentum as a key resource for providing education, guidance, and expertise to physicians and other healthcare providers in the care of women and girls with blood disorders. FWGBD’s Board and Medical Advisory Committee members (http://www.fwgbd.org/about) are leaders in clinical care and research in the area of women and blood disorders
The FWGBD Special Research Award
The overarching purpose of the award is two-fold: to support a research project in the area of bleeding disorders and their impact on women and girls that is proposed by junior faculty or fellows who are pursuing careers in the following disciplines: Adult or Pediatric Hematology; a Women's Reproductive Health speciality such as Obstetrics/Gynecology, Adolescent Medicine, or Pediatric/ Adolescent Gynecology; or another specialty that involves the care of women and girls with bleeding disorders; and 2) to further sustain an interest in translating research into clinical care that will ultimately improve the lives of these women and girls.
Research projects that will be accepted for consideration include hypothesis-generating projects in any of the following areas:
- Basic research – projects that answer fundamental biologic questions or clinically-related, laboratory-based questions
- Clinical and/or implementation research – projects that explore new treatments, medications, biomarkers and/ or diagnostic techniques or the implementation of clinical research outcomes in relevant clinical practice settings
- Translational research - projects that bridge the gap between basic and clinical science to refine and advance the application of an idea or discovery to improve healthcare delivery and/or patient outcomes
The objectives of the FWGBD Special Research Award are to:
- Create and sustain interest/knowledge of the next-generation of healthcare providers, i.e., physician-researchers working in Blood Disorders Affecting Women/Girls, with a focus, in the special award, on Bleeding Disorders
- Foster collaboration between two core disciplines for WGBD—the Hematologist or another subspecialty that involves the care of women and girls with bleeding disorders and is relevant to the Foundation's mission (e.g., Obstetrician/Gynecologist or Women’s Reproductive Health specialist, such as Adolescent Medicine Provider, Pediatric/Adolescent Gynecologist, etc.)
- Provide an opportunity for junior faculty or fellows to conduct research in this important area
Eligible applicants must:
- Submit a complete application (see criteria below)
- Be an MD or DO who is junior faculty who qualifies as an early-stage investigator (see below), or a current fellow, in Adult or Pediatric Hematology; Obstetrics/Gynecology; a Women's Reproductive Health speciality such as Adolescent Medicine or Pediatric/Adolescent Gynecology; or another specialty that involves the care of women and girls with bleeding disorders
- Have a research mentor who is mid-career or senior faculty with a research track record at the applicant’s home institution
- Demonstrate active, working collaboration with a peer in the related discipline—Women’s Reproductive Health specialty for the Hematology applicant and Hematology for the Women’s Reproductive Health specialty (or Related Career) applicant
- Have an approved or a pending IRB approval at the time of grant application submission
This award is intended as a supplemental non-salary research support grant, for a one-year period. One award will be granted at $35,000. A portion of the funding can be used toward support for a statistician and/or technician. Up to 10% of the grant award may be used toward indirect costs. A no-cost extension to two years for expending the full one-year amount will be considered based upon request from the investigator if sufficient justification can be made that a second year is necessary to complete the research project and ultimately benefit the health outcomes for women/girls with bleeding disorders.
The funding can be used toward:
- Statistical support
- Laboratory Supplies
Other non-salary items related to the research project will be considered upon request by the investigator and are subject to approval by the FWGBD Award Review Committee.
Responsibilities and Conditions
- Grants Agreement: Upon acceptance of the research grant, the awardee and FWGBD will sign a formal Grant Agreement prepared by FWGBD's legal counsel.
- Acknowledgment: Any publication, thesis, or presentation reporting the results and/or analyses of the research award shall explicitly acknowledge the support of both the Foundation for Women & Girls with Blood Disorders, as outlined in the signed Grant Agreement. Awardee agrees to provide FWGBD with a copy of any publication, abstract, or presentation reporting the results and/or analyses of the awarded project.
- Rights and Welfare of Human Subjects: The recipient is responsible for protecting the rights and welfare of human subjects in any clinical research activities involving the FWGBD awardee.
- Progress Report: Awardee is required to submit a Six-Month Progress Report (of 2-3 pages) and a Financial Report indicating the grant funds have been applied to the specified objectives of the Award. The exact deadline for submission of this report will be listed in the awardee’s Grant Agreement. Upon receipt and approval of the progress report by the FWGBD Research Award Review Committee, FWGBD will issue the final check representing full payment of the award to the recipient.
- Final Report: Awardee is required to submit a Final Narrative and Financial Report on the 12-month anniversary of the awarding of the Grant as described in the Grant Agreement and by the date listed therein.
Candidates must submit completed applications no later than 11:59 PM (EDT) on October 29, 2021, merged into one PDF document to firstname.lastname@example.org
- Award Application Form, which can be found HERE (PDF)
- Candidate’s Biosketch - Standard NIH format
- Personal Statement of applicant outlining career development plan including future career goals, significance of the research area, and how the study, if funded, will advance the applicant’s research and overall career goals (2-page limit in 11-point Arial font/.5-inch margins).
- Research Mentor’s Biosketch - Standard NIH format
- Research Mentors’ Letter(s) of Support (1 page,12-point font/.5” margins).
- Research Mentorship and Mentorship Justification - The proposal must clearly describe the following for each identified mentor:
- prior mentorship experience
- academic focus and relevance to the applicant’s proposed research
- pre-existing mentor-applicant relationship, if any
- role in the proposed project, and
- an appropriate plan for applicant/project supervision as well as progress evaluation, which includes details regarding the mentor-mentee meeting frequency and plans for scheduling these meetings (in person vs. tele-conference, etc.). NOTE: If the primary mentor and the applicant are not at the same institution, include a clear description of the supervisory and progress evaluation plans to illustrate commitment to the partnership’s success
- Letter of Support from collaborating specialist—Women’s Reproductive Health specialist or Hematologist
- Research Proposal: (2–4-page limit in 11-point Arial font, excluding references)
- Background/Importance including significance for W/G with bleeding disorders
- Hypothesis / Specific Aim(s)
- Study Design, including sample size estimation and subject selection
- Statistical Justification
- Well-Defined Study Outcomes
- Potential limitations and how they will be addressed
- Expected Timeline (through completion date of the project)
- Budget Justification
- Budget (in Excel spreadsheet)
- IRB Status (for human subjects) and/or IACUC Status (for animal studies)
Criteria for Assessing Applications
- Significance of the proposed research project to bleeding disorders in women and girls
- Interest of the applicant in bleeding disorders in women/girls as a core area of her/his career including background training
- The quality and feasibility of the research project
- The quality, experience, level of involvement, and time given by the mentor and the institution to research mentorship for the candidate, as well as an adequate research environment and the potential for training in basic, translational or clinical research
- Clear delineation of the Roles of the Mentor and the Awardee/Mentee
- The availability of cross-disciplinary collaboration, and the quality and level of this collaboration between Hematology; a Women's Reproductive Health speciality such as Obstetrics/Gynecology, Adolescent Medicine, or Pediatric/Adolescent Gynecology; or another specialty that involves the care of women and girls with bleeding disorders
- The commitment and percent (%) effort of the applicant within the context of career development
To reiterate, cross-disciplinary basic, translational or clinical research that requires a collaboration between hematology and another subspecialty relevant to the Foundation’s mission, (e.g., Ob/Gyn or other women’s/girls’ reproductive health specialty) is preferred.
All complete applications must be e-mailed by October 29, 2021. Other dates of importance are noted below:
Applications are due
October 29, 2021
Notification of award
January 3, 2022
First grant award payment
January 31, 2022
Progress Report due
July 5, 2022
Project Final Report due
December 31, 2022
Final grant award payment (contingent on the report)
January 16, 2023
*The offering of this Special Research Grant Award is made possible in part through an educational grant from Takeda.